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Abstract
Background: Pacific Krill (Euphausia pacifica) are small, red crustaceans, similar to shrimp, that flourish in the North Pacific
and are eaten in Japan.
Methods and Findings: We investigated the effect of a water-soluble extract of Pacific Krill on adipocytes and discovered
that this extract suppressed triglyceride accumulation in adipocytes. Furthermore, the water-soluble extract of Pacific Krill
suppressed the expression of two master regulators of adipocyte differentiation, peroxisome proliferator-activated receptor
gamma (PPARc) and CCAAT enhancer binding protein alpha (C/EBPa). C/EBPb promotes PPARc and C/EBPa expression, but
the water-soluble extract of Pacific Krill did not inhibit the expression of C/EBPb or C/EBPb-mediated transcriptional
activation. The Pacific Krill extract was more effective than a PPARc antagonist in suppressing PPARc and C/EBPa expression.
Conclusions: These results indicated that the water-soluble extract of Pacific Krill was not simply a PPARc antagonist, but
that it prevented triglyceride accumulation in adipocytes by suppression of PPARc and C/EBPa via a pathway that is
independent of C/EBPb.
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Introduction
Obesity increases the likelihood of various diseases, including type
2 diabetes and cardiovascular diseases. Foods that suppress
absorption of glucose and lipids [1,2] and increase the metabolism
of fat [3–6] are regarded as anti-obesity foods. Several anti-obesity
foods were studied to identify the bioactive compounds and the
physiological function of the compounds that areresponsible for their
anti-obesity effects. Foods that prevent fat accumulation also seem to
be effective in preventing obesity, but only a few studies have
investigated the foods that specifically prevent fat accumulation.
Body fat is mainly stored in adipose tissue. Adipose tissue is
generally regarded as mesodermal in origin, and mature
adipocytes develop from mesenchymal stem cells (MSCs) via a
preadipocyte stage [7]. Increases in adipose tissue mass seem to
depend on adipocyte hypertrophy because mature adipocytes have
low proliferative potential. Recently, however, it was shown that,
in adults, the number of adipocytes could increase by adipogenesis,
the differentiation of preadipocytes to mature adipocytes [8].
Adipogenesis and adipocyte hypertrophy may occur reiteratively
as an individual becomes obese; therefore, inhibition of adipogen-
esis may be an effective approach to the prevention of fat
accumulation.
Adipogenesis is regulated by PPARc and C/EBPa expression
[9]. PPARc is a nuclear hormone receptor that heterodimerizes
with the retinoid X receptor (RXR). The PPARc-RXR complex
promotes the expression of target genes and adipocyte differen-
tiation. C/EBPa is a transcription factor that is required for
adipocyte maturation [9].
Pacific Krill are small, red crustaceans, similar to shrimp, that
flourish in the North Pacific, and they have been part of Japanese
diet for seventy years. They have a high content of long-chain
polyunsaturated fatty acids, including eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA), and several studies report that
Krill Oil has anti-inflammatory effects and that it decreases serum
lipid levels [10–16]. Krill Oil has been studied as a bioactive food,
but other constituents of Krill have not been studied intensively. In
the present study, we investigated the effect of the water-soluble
extract of Pacific Krill on adipocytes and discovered that this
extract prevented triglyceride accumulation in adipocytes by
suppressing adipogenesis.
Results
The water-soluble extract of Pacific Krill suppressed
triglyceride accumulation in mouse adipocytes
To examine the effect of the water-soluble extract of Pacific
Krill on adipocytes, we cultured 3T3-F442A cells in the presence
of 10 mg/ml of insulin and 500 mg/ml of the water-soluble extract
of Pacific Krill for 10 days. We stained 3T3-F442A cells induced to
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number of differentiated adipocytes that accumulated triglyceride
within the cultures. The water-soluble extract of Pacific Krill
suppressed triglyceride accumulation in a dose-dependent manner
(Fig. 1). There were few adipocytes that had accumulated
triglycerides in the cultures treated with 500 mg/ml of the water-
soluble extract (Fig. 1B).
The water-soluble extract of Pacific Krill did not influence
the proliferation or differentiation potential of
preadipocytes
In adipocytes, differentiation and cell cycle progression
regulate each other [17–19]. To examine the effect of the
water-soluble extract of Pacific Krill on preadipocytes prolifera-
tion, we cultured 3T3-F442A cells in insulin-free medium and
counted the number of cells in the culture every 3 days to assess
the influence of the water-soluble extract on preadipocyte
proliferation. The water-soluble extract did not inhibit preadi-
pocyte proliferation (Fig. 2A). To determine whether the water-
soluble extract affected the differentiation potential of preadipo-
cytes, we cultured 3T3-F442A cells cultured in insulin-free
medium containing 500 mg/ml of the water-soluble extract of
Pacific Krill for 12 days and then induced adipocyte differenti-
ation by adding insulin (10 mg/ml) to the cultures (Fig. S4B).
3T3-F442A cell cultures pretreated with 500 mg/ml of the water-
soluble extract and the control cultures had similar numbers of
cell that accumulate triglyceride (Fig. 2B, C).
The water-soluble extract of Pacific Krill suppressed
PPARc and C/EBPa expression
PPARc and C/EBPa expression are induced during
adipogenesis [9]; therefore, we measured PPARc and C/EBPa
expression in 3T3-F442A cells cultured with 10 mg/ml of
insulin for 7 days. PPARc and C/EBPa mRNA expression
were induced in the control 3T3-F442A cells, and PPARc and
C/EBPa mRNA levels were significantly lower in the 3T3-
F442A cells treated with the water-soluble extract of Pacific
Krill than in the control cultures (Figs. 3A, S1). Moreover,
PPARc and C/EBPa protein levels were lower in the extract-
treated cultures than in the control cultures (Fig. 3B). The
expression of aP2, a gene induced by PPARc,a n dG l u t 4 ,a
marker of mature adipocytes, were also lower in cultures
treated with the water-soluble extract Pacific Krill than in
control cultures (Fig. 3A). We also examined water-soluble
extract of Antarctic Krill (Euphausia superba). The water-soluble
extract of Antarctic Krill suppressed triglyceride accumulation
and PPARc expression, but the activity was lower than the
Pacific Krill extract (Fig. S2).
Figure 1. Effect of the water-soluble extract of Pacific Krill on adipocyte differentiation. Oil Red O staining of 3T3-F442A cells that were
induced to differentiate as adipocytes and treated with (A) PBS, (B) 500 mg/ml, (C) 50 mg/ml, or (D) 5 mg/ml of the water-soluble extract of Pacific Krill
for 10 days. Scale bar, 50 mm. (E) Triglyceride measurements. Plotted values represent the mean value 6 SD from ten independent cultures. **p,0.01.
doi:10.1371/journal.pone.0021952.g001
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PLoS ONE | www.plosone.org 2 July 2011 | Volume 6 | Issue 7 | e21952Figure 2. Effects of the water-soluble extract of Pacific Krill on preadipocytes. (A) Growth curve of preadipocytes cultured with insulin-free
medium containing PBS (m) or 500 mg/ml of the water-soluble extract of Pacific Krill (N). The data points represent the mean value 6 SD from four
independent experiments. (B and C) Oil Red O staining of 3T3-F442A. These cells were cultured in insulin-free medium containing (B) PBS or (C)
500 mg/ml of the water-soluble extract of Pacific Krill for 12 days and then induced to differentiate as adipocytes by adding insulin to the culture
medium. Scale bar, 50 mm.
doi:10.1371/journal.pone.0021952.g002
Figure 3. Analysis of PPARc and C/EBPa mRNA and protein levels in 3T3-F442A cells. (A) qRT-PCR analysis of RNA extracts from 3T3-F442A
cells induced to differentiate as adipocytes for 7 days. Plotted values represent the mean value 6 SD from five independent cultures. **p,0.01;
*p,0.05. (B) Protein extracts from 3T3-F442A cells induced to differentiate as adipocytes for 7 days were analyzed by immunoblotting.
doi:10.1371/journal.pone.0021952.g003
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adipocyte differentiation in human mesenchymal stem
cells
We examined whether the water-soluble extract of Pacific Krill
also inhibited adipocyte differentiation of human mesenchymal
stem cells (hMSCs). After 13 days of adipocyte differentiation, we
added 500 mg/ml of the water-soluble extract of Pacific Krill to
hMSC medium and allowed the cultures to grow. We then
measured PPARc and C/EBPa mRNA expression levels in these
hMSCs cultures using qRT-PCR, and we stained hMSCs cultures
with Oil Red O. The water-soluble extract of Pacific Krill
suppressed PPARc and C/EBPa expression in hMSC cultures
(Fig. 4C), and the number of cells that accumulated triglycerides
were lower in the extract-treated cultures than in the control
cultures (Fig. 4A, B).
C/EBPb expression and C/EBPb-mediated transcriptional
activation were not affected by the water-soluble extract
of Pacific Krill
C/EBPb binds to the PPARc and C/EBPa promoters and
activates expression of both genes [20–22]. We assumed that the
water-soluble extract of Pacific Krill decreased the expression of
C/EBPb and C/EBPb-mediated transcriptional activation. To
test these hypotheses, we measured C/EBPb mRNA expression
levels and protein levels in extract-treated and control cultures, but
the C/EBPb mRNA and protein levels were similar in control and
extract-treated cultures (Fig. 5A, B). Next, we performed ChIP
analysis and luciferase reporter assays to examine C/EBPb-
mediated transcriptional activation. The amount of C/EBPb
bound to the PPARc and C/EBPa promoters was similar in
control and extract-treated cells (Fig. 5C). The reporter activity of
pC/EBP RE-TK hRLuc(F) construct was similar in control and
extract-treated cultures (Fig. 5D).
The water-soluble extract of Pacific Krill suppressed
PPARc and C/EBPa expression more than a PPARc
antagonist did
The PPARc antagonists bind to PPARc selectively and inhibit
PPARc function [23]. Because PPARc and C/EBPa activate each
other, the PPARc antagonists suppress PPARc and C/EBPa
expression. To assess whether the extract functioned as a PPARc
antagonist, we compared the effects of the water-soluble extract
with those of a PPARc antagonist (T0070907). Triglyceride
accumulation was suppressed by 10 mM T0070907 (Fig. 6C), and
90 mM T0070907 suppressed the expression of aP2 to the levels
found in cultures treated with the water-soluble extract of Pacific
Krill (Fig. 6D). However, while the water-soluble extract of Pacific
Krill suppressed more than 95% of PPARc and C/EBPa
expression, T0070907 suppressed less than 70% of PPARc and
C/EBPa expression (Fig. 6D).
Transcriptome analysis of 3T3-F442A cells treated with
the water-soluble extract of Pacific Krill
To identify the genes—other than PPARc and C/EBPa—that
were affected by the water-soluble extract of Pacific Krill, we
analyzed the transcriptome of 3T3-F442A cells using Super SAGE
(serial analysis of gene expression). We identified 65 genes with
expression levels that may be affected by treatment with the water-
soluble extract by comparing the transcriptome of control 3T3-
F442A cells with the transcriptome of 3T3-F442A cells cultured
with the water-soluble extract. We used qRT-PCR to confirm that
these 65 genes were affected by treatment with the extract. We
Figure 4. Influence of the water-soluble extract of Pacific Krill on adipocyte differentiation in hMSCs. After 13 days of adipocyte
differentiation, (A) PBS or (B) 500 mg/ml of the water-soluble extract of Pacific Krill were added to the cell cultures. (A and B) The Oil Red O staining of
UCB TERT-21 cells induced to differentiate as adipocytes for 22 days. Scale bar, 50 mm. (C) RNA extracts from UCB TERT-21 cells induced to
differentiate as adipocytes for 18 days were analyzed by qRT-PCR. Plotted values represent the mean value 6 SD from four independent cultures.
*p,0.05. The p value of C/EBPa was 0.059.
doi:10.1371/journal.pone.0021952.g004
Pacific Krill Extract Prevents Fat Accumulation
PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e21952identified five genes with expression levels that were increased by
the water-soluble extract (Fig. 7) and seven genes with expression
levels that were decreased (Fig. 8).
Discussion
We discovered that the water-soluble extract of Pacific Krill
prevented triglyceride accumulation by suppressing PPARc and
C/EBPa expression (Figs. 1–4). A study of PPARc
+/2 mice
shows that appropriate reduction in PPARc expression prevents
obesity induced by a high-fat diet [24]; therefore, inhibition of
PPARc expression may be an effective way to prevent obesity.
However, constitutive or complete elimination of PPARc results
in damage to adipose tissue, and this tissue plays a central role in
maintaining lipid homeostasis, energy balance, and producing
leptin and adiponectin [25–29]. Therefore, suppression, rather
than elimination of PPARc expression, may be a better way to
prevent obesity. The water-soluble extract of Pacific Krill did not
affect proliferation or differentiation of preadipocytes (Fig. 2) and
suppressed the expression of PPARc in adipocytes (Fig. 3).
Consumption of the water-soluble extract of Pacific Krill may be
a safe and effective way to prevent obesity.
Decreased C/EBPb expression and DNA binding, inhibition
of PPARc function, and activation of the Wnt/b-catenin pathway
suppresses PPARc and C/EBPa expression [9,23,29–32].
However, the water-soluble extract of Pacific Krill did not
decrease C/EBPb expression or C/EBPb-mediated transcrip-
tional activation (Fig. 5), and the extract did not increase the
expression of Nr2f2, a gene that acts downstream of Wnt/b-
catenin signal to silence PPARc expression (Fig. S3). Moreover,
the extract suppressed PPARc and C/EBPa expression more
than the PPARc antagonist did (Fig. 6). These results indicate
that the water-soluble extract of Pacific Krill was not only a
PPARc antagonist, but that it suppressed the expression of
PPARc and C/EBPa via a pathway other than those mediated
by C/EBPb or Wnt/b-catenin.
The water-soluble extract of Pacific Krill induced expression
of five genes—Angptl7, Fgf7, Tgfb1, Hgf, and Pak3; and it
suppressed expression of seveng e n e s — F g f r 2 ,P o s t n ,I d 1 ,
P k n o x 2 ,G s t a 4 ,A d a ,a n dL d l r a d 3 .F G Fs i g n a l sp o s i t i v e l y
regulate adipocyte differentiation [33–36]. While the expression
of Fgf7 was increased approximately two-fold in cells treated
with the extract, the expression of Fgfr2 was decreased to
approximately one-seventh of the level found in control cells.
These findings imply that FGF signaling was blocked in 3T3-
F442A cells treated with the extract. TGFb signal function is
antagonistic to PPARc,a n dT G F b induces myoblast differen-
tiation [37]. We propose that decreased FGF signaling and
increased TGFb signaling resulted suppression PPARc and C/
EBPa expression.
Krill Oil has been identified as a bioactive compound, and its
functions have been studied, but other components of the krill
have not been studied. This study is the first to report that the
water-soluble extract of Krill contains bioactive compound.
Furthermore, there are only a few reports that indicate that the
water-soluble components extracted from a food can suppress the
expression of PPARc; therefore, the bioactive material contained
in the water-soluble extract of Krill is of great interest. Previous
studies [10–13,38–42] and the present results indicate that Krill is
beneficial to human health because it has anti-inflammatory
effects, decreases serum lipid levels, and prevents fat accumulation
in adipocytes.
Figure 5. Effects of the water-soluble extract of Pacific Krill on C/EBPb expression and C/EBPb-mediated transcriptional activation.
(A) qRT-PCR analysis of RNA extracts from 3T3-F442A cells induced adipocyte differentiation. Plotted values are the mean value 6 SD from five
independent cultures. (B) Protein extracts from 3T3-F442A cells induced to differentiate as adipocyte for 4 days were analyzed by immunoblotting. (C)
ChIP analysis of C/EBPb ChIP samples were extracted from the 3T3-F442A cells induced to differentiate as adipocyte and cultured with or without
500 mg/ml of the water-soluble extract of Pacific Krill for 4 days. Plotted values are the mean value 6 SD from three independent experiments.
Normal Rabbit IgG was used as a negative control. (D) Luciferase reporter assay. The renilla luciferase activity was normalized to firefly luciferase
activity. Plotted values are the mean value 6 SD from eight independent experiments.
doi:10.1371/journal.pone.0021952.g005
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Water-soluble extract of Pacific Krill
A mixture of Pacific Krill and distilled water (3:1 by volume)
was homogenized, and the resulting homogenate was centrifuged
at 8000 rpm for 30 min. The supernatant was filtered and
lyophilized.
Cell culture
3T3-F442A cells from a mouse preadipocyte cell line (DS
pharma Biomedical Co., Ltd., Osaka, Japan) were cultured in
DMEM containing 10% Fetal Bovine Serum (FBS) and Antibiotic
Antimycotic Solution (Sigma-Aldrich, St Louis, MO, USA). 3T3-
F442A cells were grown until confluent on type II collagen-coated
dishes (Corning, Corning, NY, USA), and confluent cells were
induced to differentiate into adipocytes with 10 mg/ml of insulin
(Sigma-Aldrich). The culture conditions used in individual
experiments are summarized in Figure S4.
UCB TRET-21 cells, immortalized human Mesenchymal Stem
Cells, (JCRB Cell Bank, Osaka, Japan) were cultured in DMEM
containing 10% Mesenchymal Stem Cell-qualified FBS (Invitrogen,
Carlsbad, CA, USA) and Antibiotic Antimycotic Solution (Sigma-
Aldrich). UCB TERT-21 cells were induced to differentiate into
adipocytes with 10 mg/ml of insulin, 1 mM dexamethasone (Wako,
Osaka, Japan), 200 mM indomethasin (Wako), and 500 mM IBMX,
3-isobutyl-1-methylxanthine (Wako). The culture conditions used in
individual experiments are summarized in Figure S4.
Quantitative real-time PCR (qRT-PCR)
Total RNA was extracted from 3T3-F442A cells or UCB
TERT-21 cells with an RNeasy kit (QIAGEN, Tokyo, Japan) and
used to synthesize cDNA with the PrimeScript RT reagent kit
(Takara, Shiga, Japan); all kits were used according to the
manufacturers’ recommendations. Quantitative real-time PCR
was performed with the gene specific primers listed in Tables S1
and S2 and Fast SYBER Green master mix (Applied Biosystems).
The qRT-PCR data from 3T3-F442A cells were normalized to
RPLP0. The qRT-PCR data from UCB TERT-21 cells were
normalized to Actinb. The results are expressed as fold increase
compared to non-induced 3T3-F442A cells or UCB TRET-21
cells.
Oil Red O Staining
The cells induced to differentiate as adipocytes were fixed with
10% formalin (Wako) at room temperature for 10 min. Fixed cells
were washed with PBS and isopropanol solution and then stained
with 180 mg/ml of Oil Red O for 40 min. The Oil Red O-stained
cells were observed with a Nikon microscope (6400) after washing.
An Adipogenesis Assay kit (Bio Vision, Mountain View, CA, USA)
was used to measure triglyceride content.
Super serial analysis of gene expression (SAGE)
Super SAGE was performed as previously described [43–45].
Briefly, total RNA was extracted from 3T3-F442A cells with an
RNeasy kit. Double-stranded cDNA was synthesized with
Figure 6. Comparison of effects of the water-soluble extract and a PPARc antagonist on adipocyte differentiation. Oil Red O staining
of 3T3-F442A cells induced to differentiate as adipocytes and treated with (A) DMSO, (B) 500 mg/ml of the water-soluble extract of Pacific Krill, or (C)
10 mM T0070907 for 10 days. Scale bar, 50 mm. (D) Analysis of mRNA levels in 3T3-F442A cells. RNA extracts from 3T3-F442A cells induced to
differentiate as adipocytes for 7 days were analyzed by qRT-PCR. Plotted values are the mean value 6 SD from four independent cultures. **p,0.01.
doi:10.1371/journal.pone.0021952.g006
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kit (Invitrogen) from 5 mg of total RNA. Double-stranded cDNAs
were digested with NlaIII (New England Biolabs, Beverly, MA,
USA) after purification using a PCR purification kit (QIAGEN).
Double-stranded cDNAs digested with NlaIII were bound to
Dynabeads M270 streptavidin (Invitrogen). Adapter sequence 2
containing an EcoP15I restriction site was ligated to the double-
stranded cDNAs that were bound to Dynabeads. Double-stranded
cDNAs were digested with EcoP15I (New England Biolabs).
Double-stranded cDNAs digested with EcoP15I and separated
from Dynabeads were tag sequences. Adaptor sequence 1
containing index sequence was ligated to tag sequences. Tag
sequences were then amplified by PCR and gel purified. Finally,
tag sequences were analyzed using a Genome Analyzer II
(Ilumina, San Diego, CA, USA).
Super SAGE data analysis
Sorting of sequence reads (35-bases) based on index sequence
and the subsequent extraction of 26-base reference sequences
from reads was conducted using a script written in C++.T h e
reference sequences were compared to the NCBI mouse
transcript database using the BLAST program. We searched
the reference sequences, which completely matched the mouse
cDNA sequence, Tags. The total number of analyzed reads and
tags are shown in Table S3.
Chromatin immunoprecipitation (ChIP)
ChIP was performed with a ChIP Expression kit (Active motif,
Tokyo, Japan). Anti-C/EBPb (Santa Cruz, Santa Cruz, CA, USA)
and normal rabbit IgG (Santa Cruz) were used for ChIP. ChIP
samples were analyzed by gene-specific quantitative real-time PCR.
The primers used to amplify PPARc promoter sequences were 59-
CACGCCCCTCACAGAACAGTGAA-39 and 59-GCACTGTC-
CTGACTGAGAGCCA-39. The primers used to amplify C/EBPa
promoter sequences were 59-ATGCTCCCCACTCACCGCCT-39
59-GCCCCCTGGTGTCCAAACGG-39. The results are present-
ed as percent of input DNA.
Plasmids
We used the pC/EBP RE-TK hRluc(F) vector (RIKEN BRC,
Ibaraki, Japan), which uses the nucleotide sequence of the C/EBP
response element (59- GATCCGCCAATGCCAATGCCAATG -39)
found upstream of minimal thymidine kinase (TK) promoter in the
renilla luciferase reporter construct. The control vector was pmutant
C/EBP RE-TK hRluc(R) vector (RIKEN BRC), which contains the
mutant C/EBP response element(59- ACTATGACTATGAC-
Figure 7. The genes activated by the water-soluble extract of Pacific Krill. qRT-PCR analysis of RNA extracts from 3T3-F442A cells induced to
differentiate as adipocytes and treated with PBS (m) or 500 mg/ml of the water-soluble extract of Pacific Krill (N). Plotted values are the mean value 6
SD from four independent cultures.
doi:10.1371/journal.pone.0021952.g007
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The luciferase reporter assay normalization vector pCMV-Luc
contains the firefly luciferase gene driven by the cytomegarlovirus
promoter.
Luciferase reporter assay
The firefly luciferase normalization vector pCMV-Luc (0.3 mg)
and the renilla luciferase reporter construct pC/EBP RE-TK
hRluc (F) (3 mg) were co-transfected using Lipofectamin 2000
(Invitrogen) into the 3T3-F442A cells that had been induced to
differentiate into adipocytes for 3 days. One day after transfection,
the cells were harvested using passive lysis buffer (Promega).
Renilla and firefly luciferase activities were determined using a
dual luciferase assay system (Promega).
Supporting Information
Figure S1 Dose-response curve for the effects of water-
soluble extract of Pacific Krill on suppression of PPARc
gene expression. RNA extracts from 3T3-F442A cells induced
to differentiate as adipocytes and treated with the water-soluble
extract of Pacific Krill for 7 days were analyzed by qRT-PCR.
(TIFF)
Figure S2 Effects of the water-soluble extract of Antarc-
tic krill on adipocytes differentiation. Oil Red O staining of
3T3-F442A cells that were induced to differentiate as adipocytes
and treated with (A) PBS or (B) 3 mg/ml of the water-soluble
extract of Antarctic Krill for 10 days. Scale bar, 50 mm. (C) qRT-
PCR analysis of RNA extracts from 3T3-F442A cells induced to
undergo adipocyte differentiation with the water-soluble extract of
Antarctic krill for 7 days. Plotted values are the mean value from
three independent cultures.
(TIFF)
Figure S3 Influences of the water-soluble extract of
Pacific Krill on Nr2f2 expression. qRT-PCR analysis of
RNA extracts from 3T3-F442A cells induced to undergo
adipocyte differentiation for 7 days. Plotted values are the mean
value 6 SD from three independent cultures.
(TIFF)
Figure S4 Flow chart of culture conditions (A). The
culture condition of 3T3-F442A cells used to generate the data
presented in Figures 1, 3, 5–8. (B) The culture condition of 3T3-
F442A cells used to generate the data presented in Figure 2. (C)
The culture condition of UCB TERT-21 cells used to generate the
data presented in Figure 4.
(TIFF)
Table S1 The list of primers used for gene expression
analysis in 3T3-F442A cells.
(DOC)
Figure 8. The genes suppressed by the water-soluble extract of Pacific Krill. qRT-PCR analysis of RNA extracts from 3T3-F442A cells induced
to differentiate as adipocytes and treated with PBS (m) or 500 mg/ml of the water-soluble extract of Pacific Krill (N). Plotted values are the mean value
6SD from four independent cultures.
doi:10.1371/journal.pone.0021952.g008
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analysis in UCB TERT-21 cells.
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Table S3 Total number of analyzed reads and tags in
the Super SAGE analysis.
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